wise choice supplements bpc 157 BPC-157 – Mark Hyman, MD Wise Choice Supplements BPC 157

Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 3 trials

They do not replace what the drug suppresses, but they prevent nutrient deficiency from compounding the effect

Ask specific screening questions about pregnancy, lactation, and chronic conditions (pernicious anaemia, cardiac disease, hypertension) that may interact with parenteral B-12 therapy

This is the pick that makes the most sense for women who are planning to conceive, are in early pregnancy (pending physician approval), or have MTHFR concerns

Do NOT use in newborns and not to be used for inhalation

Best of luck.